CompletedNot Applicable

Comparison Between High-Intensity Laser Therapy and Extracorporeal Shockwave Therapy in the Treatment of Myofascial Pain Syndrome

Egypt32 participantsStarted 2025-10-10

Plain-language summary

this randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shockwave Therapy (ESWT) in managing patients with Myofascial Pain Syndrome (MPS). Thirty-two participants will be randomly assigned to receive either HILT or ESWT over a period of 4 weeks. Outcome measures include pain intensity (Visual Analog Scale), tenderness, functional disability, and cervical range of motion.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Male and female participants aged 18-60 years. Diagnosis of Myofascial Pain Syndrome (MPS) in the neck/shoulder region. Presence of active myofascial trigger points in the upper trapezius. Willingness to provide informed consent. Exclusion Criteria: History of cervical spine surgery, trauma, or radiculopathy. Contraindications to laser or shockwave therapy. Presence of systemic diseases (e.g., rheumatoid arthritis, malignancy). Receiving other physical therapy interventions during the study period

What they're measuring

Visual Analog Scale (VAS) for Pain Intensity

Timeframe: Baseline and 4 weeks after intervention (post-treatment)

Trial details

NCT IDNCT07176039

SponsorMTI University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-20

View on ClinicalTrials.gov More Myofascial Pain Syndrome - Neck trials